Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Current Assets (2016 - 2025)

Historic Current Assets for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $3.2 billion.

  • Chemours' Current Assets rose 425.88% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 425.88%. This contributed to the annual value of $3.0 billion for FY2024, which is 2151.4% down from last year.
  • Latest data reveals that Chemours reported Current Assets of $3.2 billion as of Q3 2025, which was up 425.88% from $3.1 billion recorded in Q2 2025.
  • In the past 5 years, Chemours' Current Assets ranged from a high of $3.8 billion in Q4 2023 and a low of $2.8 billion during Q1 2021
  • Its 5-year average for Current Assets is $3.3 billion, with a median of $3.2 billion in 2022.
  • In the last 5 years, Chemours' Current Assets surged by 2940.5% in 2021 and then tumbled by 2151.4% in 2024.
  • Quarter analysis of 5 years shows Chemours' Current Assets stood at $3.3 billion in 2021, then dropped by 3.92% to $3.2 billion in 2022, then increased by 19.6% to $3.8 billion in 2023, then dropped by 21.51% to $3.0 billion in 2024, then increased by 6.3% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q3 2025, $3.1 billion for Q2 2025, and $2.9 billion during Q1 2025.